Answers are grounded in this paper and cite their sources.
γδ T cells, which are enriched in epithelial tissues, have been used in cancer therapy because of their capacity for rapid, MHC-independent cytotoxicity. However, current paradigms largely overlook the role of tissue mechanical cues in regulating γδ T cell function. Here, we investigated how matrix viscoelasticity modulates γδ T cell migration, differentiation state, phenotype, and function, using a tunable collagen-based gel system. Slow-relaxing matrices preserved a less-differentiated phenotype, reduced migration, and increased FAS and PD-1 expression. Despite increased PD-1 expression, these cells remained functional, demonstrated by high levels of TNF-α and IFN-γ relative to PD-1-negative cells. Proteomic analysis revealed that γδ T cells respond to changes in viscoelasticity through actin remodeling and shifts in metabolic machinery. Functionally, cells encapsulated in slow-relaxing gels showed improved control of tumor growth in an aggressive HCT116 tumor model. Together, these findings establish matrix viscoelasticity as an important regulator of post-thymic γδ T cell differentiation and function.
No takes yet. Share an insight, caveat, or question.
Obuseh et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: